BFM
IMMU

Boothbay Fund Management’s Immunomedics Inc IMMU Stock Holding History

Boothbay Fund Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-28
Closed -$238K – 1599
2020
Q3 		$238K Buy
+28
New +$1.42K 0.01% 887
2020
Q2 		– Sell
-204
Closed -$275K – 1186
2020
Q1 		$275K Sell
204
-648
-76% -$10.9K 0.02% 592
2019
Q4 		$1.8M Sell
852
-180
-17% -$3.17K 0.16% 176
2019
Q3 		$1.37M Buy
1,032
+384
+59% +$5.64K 0.13% 229
2019
Q2 		$899K Hold
648
– – 0.08% 286
2019
Q1 		$1.25M Hold
648
– – 0.12% 187
2018
Q4 		$925K Buy
+648
New +$12.9K 0.13% 157
2018
Q1 		– Sell
-748
Closed -$1.21M – 948
2017
Q4 		$1.21M Hold
748
– – 0.18% 109
2017
Q3 		$1.05M Sell
748
-108,252
-99% -$1.08M 0.17% 141
2017
Q2 		$962K Buy
109,000
+67,700
+164% +$475K 0.2% 105
2017
Q1 		$267K Buy
+41,300
New +$209K 0.05% 475

Boothbay Fund Management's IMMU Position: Q4 2020 in Review

Boothbay Fund Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 4,301 shares — an estimated $366K sold.

Boothbay Fund Management first reported a position in IMMU in Q4 2016 and held it in 2 quarters. The position peaked at $366K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Boothbay Fund Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Boothbay Fund Management sold 4,301 Immunomedics Inc shares in Q4 2020, an estimated $366K.
  • Boothbay Fund Management first reported a position in Immunomedics Inc in Q4 2016 and held it in 2 quarters.
  • Boothbay Fund Management's Immunomedics Inc position peaked at $366K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Boothbay Fund Management's 13F filing for Q4 2020, filed 12 Feb 2021.